Trinity Biotech plc (TRIB)

IE — Healthcare Sector
Peers: STRRP  LAB  GTH  BDSX  NDRA  SERA  OLK  FONR  STIM  XGN  SHC  ACRS  CSTL  PRE  MDXH  NOTV 

Automate Your Wheel Strategy on TRIB

With Tiblio's Option Bot, you can configure your own wheel strategy including TRIB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TRIB
  • Rev/Share 0.2846
  • Book/Share -0.1268
  • PB -0.2957
  • Debt/Equity -3.5576
  • CurrentRatio 1.6425
  • ROIC -0.1826

 

  • MktCap 13940588.0
  • FreeCF/Share -0.0902
  • PFCF -0.7442
  • PE -0.3831
  • Debt/Assets 0.9617
  • DivYield 0
  • ROE 0.7932

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Trinity Biotech plc (TRIB)

  • IPO Date 1992-10-21
  • Website https://www.trinitybiotech.com
  • Industry Medical - Diagnostics & Research
  • CEO John Gillard
  • Employees 380
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.